Fiji vs Mexico: Statin use vs. average non-HDL cholesterol levels
Fiji
3.8
in 2018
Mexico
3.8
in 2018
Fiji rank
6th
Mexico rank
6th
Statin use vs. average non-HDL cholesterol levels over time
- Fiji
- Mexico
How they compare
Fiji currently reports 3.8 against 3.8 in Mexico, a difference of 0.
The two have swapped places 4 times across 39 shared years of data; in 1980 it was Mexico ahead.
Fiji ranks 6th and Mexico ranks 6th of 191 countries.
Across the 4 decades both report, Fiji averaged higher in 3 and Mexico in 1.
Head to head by decade
| Decade | Fiji | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.83 | 3.9 | 0.07 | Mexico |
| 1990s | 3.95 | 3.9 | 0.05 | Fiji |
| 2000s | 3.95 | 3.89 | 0.06 | Fiji |
| 2010s | 3.84 | 3.8 | 0.0444 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Fiji or Mexico?
- Fiji, at 3.8 against 3.8 in Mexico as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Fiji and Mexico?
- 0, with Fiji ahead.
- How many years of comparable data are there for Fiji and Mexico?
- 39 years are reported by both, from 1980 to 2018.
- How do Fiji and Mexico rank globally for statin use vs. average non-hdl cholesterol levels?
- Fiji ranks 6th and Mexico ranks 6th of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.